388 related articles for article (PubMed ID: 30880956)
1. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
Kumar P; Agnihotri S; Roy I
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
[TBL] [Abstract][Full Text] [Related]
2. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
[TBL] [Abstract][Full Text] [Related]
3. Iron oxide-doped niosomes as drug carriers for magnetically targeted drug delivery.
Juneja R; Roy I
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):7-9. PubMed ID: 29593388
[TBL] [Abstract][Full Text] [Related]
4. Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.
Zakaria MB; Belik AA; Liu CH; Hsieh HY; Liao YT; Malgras V; Yamauchi Y; Wu KC
Chem Asian J; 2015 Jul; 10(7):1457-62. PubMed ID: 25944287
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
[TBL] [Abstract][Full Text] [Related]
6. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery.
Estelrich J; Escribano E; Queralt J; Busquets MA
Int J Mol Sci; 2015 Apr; 16(4):8070-101. PubMed ID: 25867479
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.
Liang PC; Chen YC; Chiang CF; Mo LR; Wei SY; Hsieh WY; Lin WL
Int J Nanomedicine; 2016; 11():2021-37. PubMed ID: 27274233
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy.
Sun X; Liu B; Chen X; Lin H; Peng Y; Li Y; Zheng H; Xu Y; Ou X; Yan S; Wu Z; Deng S; Zhang L; Zhao P
J Mater Sci Mater Med; 2019 Jun; 30(7):76. PubMed ID: 31218573
[TBL] [Abstract][Full Text] [Related]
9. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
10. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
11. Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery.
Kralj S; Potrc T; Kocbek P; Marchesan S; Makovec D
Curr Med Chem; 2017; 24(5):454-469. PubMed ID: 27528059
[TBL] [Abstract][Full Text] [Related]
12. Poly-paclitaxel/cyclodextrin-SPION nano-assembly for magnetically guided drug delivery system.
Jeon H; Kim J; Lee YM; Kim J; Choi HW; Lee J; Park H; Kang Y; Kim IS; Lee BH; Hoffman AS; Kim WJ
J Control Release; 2016 Jun; 231():68-76. PubMed ID: 26780174
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
Sabnis S; Sabnis NA; Raut S; Lacko AG
Int J Nanomedicine; 2017; 12():1453-1464. PubMed ID: 28260891
[TBL] [Abstract][Full Text] [Related]
14. Blocking Interleukin-4 Receptor α Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation.
Shaik AP; Shaik AS; Majwal AA; Faraj AA
Cancer Res Treat; 2017 Apr; 49(2):322-329. PubMed ID: 27456946
[TBL] [Abstract][Full Text] [Related]
15. The comparison between superparamagnetic and ferromagnetic iron oxide nanoparticles for cancer nanotherapy in the magnetic resonance system.
Orel VE; Tselepi M; Mitrelias T; Zabolotny M; Shevchenko A; Rykhalskyi A; Romanov A; Orel VB; Burlaka A; Lukin S; Kyiashko V; Barnes CHW
Nanotechnology; 2019 Oct; 30(41):415701. PubMed ID: 31265997
[TBL] [Abstract][Full Text] [Related]
16. Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate.
Nowicka AM; Kowalczyk A; Jarzebinska A; Donten M; Krysinski P; Stojek Z; Augustin E; Mazerska Z
Biomacromolecules; 2013 Mar; 14(3):828-33. PubMed ID: 23327587
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
Guo M; Que C; Wang C; Liu X; Yan H; Liu K
Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
[TBL] [Abstract][Full Text] [Related]
18. Investigation of novel superparamagnetic Ni
Qasim M; Asghar K; Dharmapuri G; Das D
Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
[TBL] [Abstract][Full Text] [Related]
19. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
20. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]